Literature DB >> 8645807

Life-threatening neutropenia secondary to piperacillin/tazobactam therapy.

L Gerber1, E J Wing.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8645807     DOI： 10.1093/clinids/21.4.1047-a

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  4 in total

Review 1.  Systematic review of piperacillin-induced neutropenia.

Authors:  Marc H Scheetz; June M McKoy; Jorge P Parada; Benjamin Djulbegovic; Dennis W Raisch; Paul R Yarnold; Jessica Zagory; Steve Trifilio; Rita Jakiche; Frank Palella; Adam Kahn; Kevin Chandler; Charles L Bennett
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

2.  Risk of Neutropenia in Adults Treated with Piperacillin-Tazobactam or Cefazolin: A Retrospective Cohort Study.

Authors:  Marie-Pier Roy; Frédéric Calon; David Simonyan; Luc Bergeron
Journal:  Can J Hosp Pharm       Date:  2022-07-04

3.  Assessing the Effect of Piperacillin/Tazobactam on Hematological Parameters in Patients Admitted with Moderate or Severe Foot Infections.

Authors:  Will Fry; Sean McCafferty; Catherine Gooday; Ian Nunney; Ketan K Dhatariya
Journal:  Diabetes Ther       Date:  2018-01-04       Impact factor: 2.945

4.  Piperacillin induced bone marrow suppression: a case report.

Authors:  Ashish Kumar; Gourdas Choudhuri; Rakesh Aggarwal
Journal:  BMC Clin Pharmacol       Date:  2003-06-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.